ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
MetVital Announces FDA Clearance AEO Testing for Glioblastoma Multiforme americanpharmaceuticalreview
June 13, 2019MetVital announced the U.S. Food and Drug Administration (FDA) has notified MetVital that it may proceed with its clinical investigation of "Anhydrous Enol-Oxaloacetate" (AEO) as a potential treatment for patients with Glioblastoma Multiforme.
Pharma Sources Insight July 2025
